Patient-rated suitability of a novel electronic device for self-injection of subcutaneous interferon beta-1a in relapsing multiple sclerosis: an international, single-arm, multicentre, Phase IIIb study

Patient-rated suitability of a novel electronic device for self-injection of subcutaneous interferon beta-1a in relapsing multiple sclerosis: an international, single-arm, multicentre, Phase IIIb study

<p>Abstract</p> <p>Background</p> <p>Multiple sclerosis (MS) currently requires long-term treatment with disease-modifying drugs, administered parenterally up to once daily. The need for regular self-injection can be a barrier to treatment for many patients. Autoinjecto...

Full description

Bibliographic Details
Main Authors: Verdun di Cantogno Elisabetta, Singer Barry, Lugaresi Alessandra, Lang Michael, Borre Björn, Arbizu Txomin, Devonshire Virginia, Cornelisse Peter
Format: Article
Language:English
Published: BMC 2010-04-01
Series:BMC Neurology
Online Access:http://www.biomedcentral.com/1471-2377/10/28

Similar Items

Similar Items